High materiality7/10
Cogent Biosciences price target raised to $52 from $45 at Guggenheim
Why it may matterVerify against the original reporting
Buy on upgraded price target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises COGT target to $52; current price reported at $38.7.
- Guggenheim target up to 52
- COGT price $38.7
Key facts
- 01
Target: $52
- 02
Posted price: $38.7
- 03
Analyst firm: Guggenheim
- 04
Analyst: Michael Schmidt
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.